{
  "id": 16724254,
  "title": "Hanmi Pharm Q3 net income down 69.1% to $10.6 mil.",
  "url": "https://urgent.news/2026/10/27/hanmi-pharm-q3-net-income-down-69-1-to-10-6-mil",
  "topic": "world",
  "section": "World",
  "published": "2026-10-27T08:02:03.000Z",
  "source": {
    "name": "The Korea Times",
    "slug": "the-korea-times-koreatimes",
    "url": "https://www.koreatimes.co.kr/business/companies/20261027/hanmi-pharm-q3-net-income-down-691-to-106-mil"
  },
  "original_language": "en",
  "account": null,
  "summary": "Hanmi Pharm on Tuesday reported a third-quarter net income of 14 billion won ($10.6 million), down 69.1 percent from a year earlier. The Korean pharmaceutical company said in a regulatory filing that operating profit for the July-September period fell 31.3 percent on-year to 37.8 billion won. Revenue increased 4.2 percent to 377.4 billion won. The earnings failed to meet market expectations. The…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}